← FDA Drug Approvals (Drugs@FDA)
SITAGLIPTIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UMEDICA LABORATORIES PRIVATE LIMITED · Approved 2026-07-20
Drug application
- FDA Application #
ANDA217979- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SITAGLIPTIN
- Generic name
- Sitagliptin
- Active ingredients
- SITAGLIPTIN
- Dosage form
- TABLET
- Route
- —
- Marketing status
- None (Tentative Approval)
- Sponsor
- UMEDICA LABORATORIES PRIVATE LIMITED
- First approval
- 2026-07-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown